Tuesday, June 16, 2020

Clinical Laboratory Services Market Set for Rapid Growth to Reach CAGR of over 6.4% by 2030 - DaVita, Eurofins Scientific

Clinical laboratory services are the medical tests provided by the medical laboratory that help in further diagnosis and treatment of individuals. A medical laboratory offers various services comprising hemoglobin tests, liver function tests, diagnostic testing, urinalysis, immunology and allergic testing, therapeutic drug monitoring, spinal fluid analysis, cholesterol tests, transfusion medicine, pathology, and blood count. Clinical laboratory services are elected when the required budget to obtain the tests is comparatively less than expected or when there is a need for higher volume analysis. These services differ from laboratory to laboratory. These differences help the patient to choose the right medical laboratory where the required services are available.

The market growth of clinical laboratory services can be attributed to factors, such as advancements in clinical testing techniques, growing geriatric population, new diseases demanding accurate & early diagnosis, and growing prevalence of target diseases. In 2019, Quest Diagnostics presented data for its HDL cholesterol function lab test that provides insights into cardiovascular disease risks at the American Heart Association Scientific Sessions. This could help people to avoid adverse outcomes through early detection and preventive care. These are some of the factors that will drive market growth during the forecast period.

Major Key Players of the Clinical Laboratory Services Market are:Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, DaVita Inc., Eurofins Scientific, Fresenius Medical Care AG & Co. KGaA, Mayo Foundation for Medical Education and Research, Sonic Healthcare, BioReference Laboratories, Inc., Laboratoire Cerba, ACM Global Laboratories, and others.

Read More @ http://www.sbwire.com/press-releases/covid-19-impact-on-clinical-laboratory-services-market-set-for-rapid-growth-to-reach-cagr-of-over-64-by-2030-davita-eurofins-scientific-1290873.htm 


No comments:

Post a Comment